It appears as though Bill Freytag, Ph.D. former chief executive of Myogen will be assuming the CEO and chair positions with Aspreva Pharmaceuticals (NASDAQ: ASPV) effective immediately. We wish him the best of luck in this next chapter and appreciate all that Dr. Freytag has done for the Colorado life science landscape. Aspreva, based in [...]

• 193http://clsdf.com/2007/07/j-william-freytag-ceo-of-aspreva-pharma/J.+William+Freytag%3A+CEO+of+Aspreva+Pharma2007-07-12+05%3A36%3A00admin

Congratulations to Arlen Meyers, MD, MBA who has been appointed as the Academic Director of the Bard Center Bioentrepreneurship Program. Program details may be found (here). The inaugural Class I Bard Bio Fellows are off to the races. The Fellows among others will be taking Dr. Meyers Fundamentals of Bioscience Technology Transfer course beginning in [...]

• 192http://clsdf.com/2007/07/new-bioentrepreneur-director-at-bard/New+Bioentrepreneur+Director+at+Bard2007-07-11+16%3A05%3A00admin